NJ health insurers must cover biomarker precision testing when clinically indicated for diagnosis or disease management, per FDA/CMS guidance and comparable cost sharing.

Requires the NY Office of Victim Services to establish procedures to notify crime victims about the Address Confidentiality Program and connect them with ACP resources.

Requires certain covered platforms to provide a law-enforcement contact process and to comply with search warrants within 72 hours, speeding access to data for investigations.

Protects the communication rights of individuals with disabilities by requiring accessible communication supports from public entities and service providers.

Bill A 2202 regulates topical pharmaceutical agents, ensuring safe use through guidelines, training for healthcare providers, and enhanced patient safety measures.